Solitary melanoma confined to the dermal and/or subcutaneous tissue: Evidence for revisiting the staging classification

Archives of Dermatology

Volumn 136, Issue 11, 2000, Pages 1397-1399

  Bowen, Glen M ^b   Chang, Alfred E ^c   Lowe, Lori ^c   Hamilton, Ted ^c   Patel, Rupa ^c   Johnson, Timothy M ^a,c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; DERMIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL; SUBCUTANEOUS TISSUE; TUMOR LOCALIZATION;

ADULT; AGED; AGED, 80 AND OVER; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MEDICAL RECORDS; MELANOMA; MICHIGAN; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, UNKNOWN PRIMARY; PREVALENCE; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; SURVIVAL ANALYSIS;

EID: 0033755662     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: A summary of 84,836 cases from the past decade
2. Metastatic melanoma of unknown primary origin shows prognostic similarities to regional metastatic melanoma: Recommendations for initial staging examinations
3. Malignant melanoma: The patient with an unknown site of primary origin
4. Metastatic melanoma of unknown primary
5. Clinical aspects of unknown primary melanoma
6. Occult primary malignant melanoma: Factors influencing survival
7. Metastatic malignant melanoma with an unknown primary
8. Malignant melanoma of unknown primary
9. Melanoma of unknown primary site: Presentation, treatment, and prognosis - A single institution study
10. Current therapy of cutaneous melanoma